Arthur Géraud
Impact in
-
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
- HER2/EGFR in Cancer Research
-
- Brain Metastases and Treatment
- Lung Cancer Treatments and Mutations
- Renal cell carcinoma treatment
Papers in
- Oncology 12
- Cancer Immunotherapy and Biomarkers 4
- Cancer Treatment and Pharmacology 3
- Lung Cancer Research Studies 2
-
- Lung Cancer Treatments and Mutations 5
- Renal cell carcinoma treatment 2
- Co-authors
- Youlia Kirova (2 shared papers)Paul Gougis (7 shared papers)Philippe Beuzeboc (1 shared paper)Hao Xu (1 shared paper)Olivier Mir (8 shared papers)Marc Hilmi (3 shared papers)Christian Funck‐Brentano (3 shared papers)C. Anquetil (1 shared paper)
- Journals
- ESMO Open (4 papers)Annals of Oncology (3 papers)Journal of Thoracic Oncology (2 papers)The Annual Review of Pharmacology and Toxicology (1 paper)Critical Reviews in Oncology/Hematology (1 paper)
- Partner nations
- FranceUnited StatesItaly
In The Last Decade
Arthur Géraud
23 papers receiving 286 citations
Peers
Comparison fields: 5 of 65
- Oncology 123
- Pulmonary and Respiratory Medicine 95
- Cancer Research 31
- Pharmacology 19
- Genetics 12
Countries citing papers authored by Arthur Géraud
This map shows the geographic impact of Arthur Géraud's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arthur Géraud with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arthur Géraud more than expected).
Fields of papers citing papers by Arthur Géraud
This network shows the impact of papers produced by Arthur Géraud. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arthur Géraud. The network helps show where Arthur Géraud may publish in the future.
Co-authors
The 25 scholars most cited alongside Arthur Géraud, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 62 | |
| 2 | 2016 | 52 | |
| 3 | 2021 | 41 | |
| 4 | 2017 | 31 | |
| 5 | 2021 | 25 | |
| 6 | 2007 | 17 | |
| 7 | 2021 | 12 | |
| 8 | 2018 | 11 | |
| 9 | 2021 | 10 | |
| 10 | 2021 | 5 | |
| 11 | 2020 | 5 | |
| 12 | 2022 | 3 | |
| 13 | 2021 | 3 | |
| 14 | 2020 | 3 | |
| 15 | 2023 | 2 | |
| 16 | 2019 | 2 | |
| 17 | 2024 | 1 | |
| 18 | 2021 | 1 | |
| 19 | 2024 | 1 | |
| 20 | 2021 | 1 |
About Arthur Géraud
Arthur Géraud is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Surgery and Molecular Biology, having authored 25 papers that have together received 291 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (5 papers), Cancer Genomics and Diagnostics (4 papers), Cancer Immunotherapy and Biomarkers (4 papers), Cancer Treatment and Pharmacology (3 papers), Renal cell carcinoma treatment (2 papers), Chronic Myeloid Leukemia Treatments (2 papers), Lung Cancer Research Studies (2 papers) and Bladder and Urothelial Cancer Treatments (2 papers). The work is most often cited by research in Oncology (123 citations), Pulmonary and Respiratory Medicine (95 citations), Cancer Research (31 citations), Pharmacology (19 citations) and Genetics (12 citations). Arthur Géraud has collaborated with scholars based in France, United States and Italy. Frequent co-authors include Youlia Kirova, Paul Gougis, Philippe Beuzeboc, Hao Xu, Olivier Mir, Marc Hilmi, Christian Funck‐Brentano, C. Anquetil, Elisa Funck‐Brentano and Emanuela Romano. Their work appears in journals such as ESMO Open, Annals of Oncology, Journal of Thoracic Oncology, The Annual Review of Pharmacology and Toxicology and Critical Reviews in Oncology/Hematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.